We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.78%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.58B
AUM Growth
+$312M
Cap. Flow
+$159M
Cap. Flow %
6.16%
Top 10 Hldgs %
33.71%
Holding
96
New
19
Increased
23
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$59M
2
SYK icon
Stryker
SYK
+$39M
3
ALKS icon
Alkermes
ALKS
+$34.9M
4
ICLR icon
Icon
ICLR
+$31.7M
5
ABBV icon
AbbVie
ABBV
+$31.6M

Top Sells

Rank Stock Value
1
QURE icon
uniQure
QURE
+$38.8M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$35.7M
3
AVTR icon
Avantor
AVTR
+$28.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$21.7M
5
ICUI icon
ICU Medical
ICUI
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$140M 5.44%
298,643
– –
PEN icon
2
Penumbra
PEN
$12.5B
$124M 4.81%
360,030
– –
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$112M 4.36%
1,091,840
– –
CYTK icon
4
Cytokinetics
CYTK
$11B
$78.3M 3.04%
2,399,545
– –
CNC icon
5
Centene
CNC
$32.5B
$75M 2.91%
1,112,480
– –
HUM icon
6
Humana
HUM
$47.8B
$74.3M 2.88%
166,066
– –
MRK icon
7
Merck
MRK
$312B
$68.8M 2.67%
596,261
+135,143
+29% +$15.3M
ABBV icon
8
AbbVie
ABBV
$452B
$68M 2.64%
504,498
+215,595
+75% +$31.6M
EW icon
9
Edwards Lifesciences
EW
$48.9B
$66.3M 2.57%
702,588
+53,955
+8% +$4.69M
RSP icon
10
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$95.7B
$61.4M 2.38%
+410,100
New +$59.1M
CAH icon
11
Cardinal Health
CAH
$52.9B
$60.5M 2.35%
639,783
– –
ISRG icon
12
Intuitive Surgical
ISRG
$124B
$58.8M 2.28%
172,043
-6,820
-4% -$2.06M
BIIB icon
13
Biogen
BIIB
$29.5B
$56.5M 2.19%
+198,334
New +$59M
UNH icon
14
UnitedHealth
UNH
$396B
$55.8M 2.17%
116,067
– –
ICLR icon
15
Icon
ICLR
$12.8B
$53.4M 2.07%
213,559
+149,142
+232% +$31.7M
PRTA icon
16
Prothena Corp
PRTA
$454M
$52.9M 2.05%
774,546
– –
IRTC icon
17
iRhythm Holdings
IRTC
$3.58B
$50.6M 1.97%
485,468
– –
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
$49.3M 1.92%
256,299
+35,416
+16% +$7.04M
HCA icon
19
HCA Healthcare
HCA
$82.8B
$48.2M 1.87%
158,772
+10,272
+7% +$2.86M
DXCM icon
20
DexCom
DXCM
$28.8B
$48.1M 1.87%
374,478
-49,338
-12% -$5.97M
LEGN icon
21
Legend Biotech
LEGN
$4.55B
$46.9M 1.82%
679,076
+206,915
+44% +$13.5M
SNDX icon
22
Syndax Pharmaceuticals
SNDX
$1.98B
$45.5M 1.77%
2,172,437
+225,785
+12% +$4.7M
MCK icon
23
McKesson
MCK
$97.3B
$45.2M 1.76%
105,811
– –
IQV icon
24
IQVIA
IQV
$34B
$45.2M 1.75%
201,037
– –
UHS icon
25
Universal Health Services
UHS
$9.08B
$44.7M 1.74%
283,257
+49,572
+21% +$6.91M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q2 2023 Portfolio in Review

As of Q2 2023, PFM Health Sciences held 96 positions worth $2.58B, up 14% from $2.26B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences deployed $159M of net new capital in Q2 2023, opening 19 new positions and adding to 23 existing holdings. Its largest new stake was Biogen: 198,334 shares worth $56.5M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier.

On the sell side, the largest reduction was uniQure, an estimated $38.8M trimmed.

  • PFM Health Sciences's largest Q2 2023 buy was Biogen: 198,334 shares worth $56.5M.
  • PFM Health Sciences added most to Icon in Q2 2023, an estimated $31.7M increase.
  • PFM Health Sciences's biggest Q2 2023 reduction was uniQure, cutting an estimated $38.8M.
  • PFM Health Sciences fully exited IVERIC bio, Inc. Common Stock in Q2 2023, selling an estimated $35.7M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $2.58B portfolio in Q2 2023.
  • PFM Health Sciences opened 19 new positions and closed 13 in Q2 2023.
  • PFM Health Sciences's portfolio value rose 14% quarter-over-quarter to $2.58B.

Based on PFM Health Sciences's 13F filing for Q2 2023, filed 14 Aug 2023.